Picture of Bionoid Pharma logo

BINP Bionoid Pharma Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall Cap

Annual cashflow statement for Bionoid Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

C2007
December 31st
2008
December 31st
2009
December 31st
2010
December 31st
2011
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-KARS
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.26-1.59-3.41-3.91-5.14
Depreciation
Non-Cash Items0.4360.7872.321.873.43
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.2530.390.5660.2670.897
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-0.531-0.369-0.484-1.73-0.809
Capital Expenditures-0.001-0.005-0.002-0.011-0.01
Purchase of Fixed Assets
Cash from Investing Activities-0.001-0.005-0.002-0.011-0.01
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.5080.4210.5792.57-0.158
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.0040.0190.1120.837-0.983

Or unlock with your email

Or unlock with your email